New Thiol Inhibitors of Neutral Endopeptidase EC 3.4.24.11: Synthesis and Enzyme Active-Site Recognition

• Published in: Journal of medicinal chemistry Vol. 37; no. 12; pp. 1865 - 1873
• Main Authors: Gomez-Monterrey, Isabel, Beaumont, Ann, Nemecek, Patrick, Roques, Bernard P, Fournie-Zaluski, Marie-Claude
• Format: Journal Article
• Language: English
• Published: WASHINGTON American Chemical Society 01.06.1994; Amer Chemical Soc
• Subjects: Amino Acid Sequence; Animals; Antihypertensive agents; Binding Sites; Biological and medical sciences; Cardiovascular system; Chemistry, Medicinal; Humans; Life Sciences & Biomedicine; Medical sciences; Molecular Sequence Data; Neprilysin - antagonists & inhibitors; Neprilysin - metabolism; Pharmacology & Pharmacy; Pharmacology. Drug treatments; Rabbits; Science & Technology; Substrate Specificity; Sulfhydryl Compounds - chemical synthesis; Sulfhydryl Compounds - metabolism; Sulfhydryl Compounds - pharmacology; ZINC PEPTIDASES; 24.11 ENKEPHALINASE; THERMOLYSIN; SPECIFICITY; ENKEPHALIN-DEGRADING ENZYMES; PHYSICAL-DEPENDENCE; MIXED INHIBITOR; MOLECULAR-CLONING; ANGIOTENSIN-CONVERTING ENZYME; AMINO-ACID SEQUENCE; Thiol; Enzyme; Active site; Enzyme inhibitor; Metalloendopeptidases; Molecular interaction; In vitro; α-Aminoacid; Structure activity relation; Peptidyl-dipeptidase A; Aminoacid; Hydrolases; Peptidyl-dipeptidases; Antihypertensive agent; Neprilysin; Chemical synthesis; Proteinases
• ISSN: 0022-2623; 1520-4804
• DOI: 10.1021/jm00038a016

Selective, as well as mixed, inhibitors of the two zinc metallopeptidases, neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE), are of major clinical interest in the treatment of hypertension and cardiac failure. New thiol inhibitors, corresponding to the general formula HS-CH(R(1))-CH2-CH(R(2))-CONH-CH(R(3))-COOH, were designed in order to explore the putative S-1 subsite of the active site of NEP. The inhibitors were also tested on ACE and the most representative on thermolysin (TLN) for comparison. The relatively low inhibitory potencies exhibited by these compounds (IC(50)s in the 10(-7) M range for NEP and in the 10(-6) M range for ACE) as compared to that of thiorphan (IC(50)s 2 10 X 10(-9) M on NEP and 1.40 x 10(-7) M on ACE) clearly indicate the absence of the expected energetically favorable interactions with the active site of both peptidases. A 100-fold loss of potency for these inhibitors was also observed for thermolysin as compared to thiorphan. Using the mutated Glu(102)-NEP, it was possible to demonstrate that the inhibitors do not fit the S-1 subsite of NEP but interact with the S-1' and S-2' subsites through binding of their R(1) and R(2) residues and that the C-terminal amino acid is located outside the active site. These results seem to indicate that these thiol inhibitors are not well. adapted for optimal recognition of the S-1 subsite of NEP, and probably ACE, and that other zinc-chelating moieties such as carboxylate or phosphonate groups may be preferred for this purpose.